Amussen Hunsaker Associates LLC Novartis Ag Transaction History

Amussen Hunsaker Associates LLC

  • $715 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $177,422 - $196,560
2,160 New
2,160 $188,000
Q3 2018

Nov 16, 2018
SELL
$66.94 - $77.43 $6,694 - $7,743
-100 Closed
0 $0
Q2 2018

Aug 16, 2018
BUY
$64.91 - $73.36 $6,491 - $7,336
100 New
100 $8,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email